[go: up one dir, main page]

AR010432A1 - PHARMACEUTICAL COMPOSITIONS CONTAINING RICHINOLEIC ACID AND ITS USE FOR ANTI-INFLAMMATORY AND ANALGESIC THERAPY - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING RICHINOLEIC ACID AND ITS USE FOR ANTI-INFLAMMATORY AND ANALGESIC THERAPY

Info

Publication number
AR010432A1
AR010432A1 ARP980104875A AR010432A1 AR 010432 A1 AR010432 A1 AR 010432A1 AR P980104875 A ARP980104875 A AR P980104875A AR 010432 A1 AR010432 A1 AR 010432A1
Authority
AR
Argentina
Prior art keywords
inflammatory
pharmaceutical compositions
compositions containing
acid
richinoleic
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Spa filed Critical Menarini Ricerche Spa
Publication of AR010432A1 publication Critical patent/AR010432A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composicones farmacéuticas que contienen como principio activo ácido ricinoleico y su utilizacion para tratamientos de estados dolorosos,inflamatorios y alérgicos. Con tal finalidad se describe el uso del ácido ricinoleico, sus ésteres osales farmacéuticamente aceptables para eltratamiento de estados dolorosos, inflamatorios y alérgicos.Pharmaceutical compositions containing ricinoleic acid as active ingredient and its use for treatments of painful, inflammatory and allergic states. For this purpose, the use of ricinoleic acid, its pharmaceutically acceptable osal esters for the treatment of painful, inflammatory and allergic states, is described.

ARP980104875 1997-09-29 1998-09-30 PHARMACEUTICAL COMPOSITIONS CONTAINING RICHINOLEIC ACID AND ITS USE FOR ANTI-INFLAMMATORY AND ANALGESIC THERAPY AR010432A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI970217 IT1295658B1 (en) 1997-09-29 1997-09-29 PHARMACEUTICAL COMPOSITIONS CONTAINING RICINOLEIC ACID AND THEIR USE FOR ANTI-FLAMMATORY AND ANALGESIC THERAPY

Publications (1)

Publication Number Publication Date
AR010432A1 true AR010432A1 (en) 2000-06-07

Family

ID=11352253

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104875 AR010432A1 (en) 1997-09-29 1998-09-30 PHARMACEUTICAL COMPOSITIONS CONTAINING RICHINOLEIC ACID AND ITS USE FOR ANTI-INFLAMMATORY AND ANALGESIC THERAPY

Country Status (4)

Country Link
AR (1) AR010432A1 (en)
AU (1) AU1026399A (en)
IT (1) IT1295658B1 (en)
WO (1) WO1999016435A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05011189A (en) * 2003-04-17 2006-05-25 Gen Hospital Corp Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid.
EP2557947A1 (en) 2010-04-14 2013-02-20 Altria Client Services Inc. Preformed smokeless tobacco product
EP2913051B1 (en) * 2012-10-29 2018-09-19 Kyoto University Metabolism-improving agent comprising rare fatty acid
CN104994846B (en) * 2013-02-21 2018-01-19 国立大学法人京都大学 Intestinal protection containing hydroxylated fatty acid
US9572844B2 (en) 2013-02-22 2017-02-21 Nitto Pharmaceutical Industries, Ltd. Immunostimulation agent
US10799548B2 (en) * 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
CN106163511A (en) * 2014-01-24 2016-11-23 国立大学法人京都大学 Antiinflammatory containing rare fatty acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2423397A1 (en) * 1974-05-14 1975-11-27 Heimbach Irmgard Deep-acting collodion solution medicament - contg. Terebinthina, castor oil, plant extracts, and salicylic acid
DE2426393C3 (en) * 1974-05-31 1981-09-03 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Ready-to-use liquid gargle with antimicrobial effectiveness
FR2485001A1 (en) * 1980-06-02 1981-12-24 Svatos Antonin 4-Chloro and 2,4-di:chloro 3,5-xylyl ricinoleate(s) - used as fungicides, insecticides, parasiticides and antiinflammatories
US4919934A (en) * 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
ATE198757T1 (en) * 1989-08-29 2001-02-15 Univ Virginia Commonwealth CYTOPROTECTIVE SUBSTANCES WITH UNSATURATED HYDROCARBON RESIDUE OF 16 TO 20 CARBON ATOMS
US5686488A (en) * 1995-08-25 1997-11-11 Alcon Laboratories, Inc. Polyethoxylated castor oil products as anti-inflammatory agents
DE19544507B4 (en) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin containing preparations

Also Published As

Publication number Publication date
AU1026399A (en) 1999-04-23
ITFI970217A1 (en) 1999-03-29
IT1295658B1 (en) 1999-05-24
WO1999016435A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
ATE323473T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RESVERATROL AND USES THEREOF
ES2069410T3 (en) NEW DERIVATIVES OF HYDROXAMIC ACID AND N-HYDROXYUREA AND ITS USE.
DE69826644D1 (en) TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING A CHOLINERGIC ACTIVE SUBSTANCE OR A CALCIUM CHANNEL BLOCKER
MX9300977A (en) HETEROBICICLIC COMPOUNDS.
DE69930259D1 (en) COMPOSITIONS FOR THE USE OF INFLAMMATORY INHIBITORS, ESPECIALLY ANTISEPTIC AND / OR WOUND HEALING AGENTS IN THE UPPER RESPONSE AND / OR EAR
BR0209283A (en) Method for the manufacture of a low dosage pharmaceutical composition having uniform drug distribution and potency
ES2184145T3 (en) SULPHONIC ACID OR SULFONYLAMINE ACIDS-N- (HETEROARALQUIL) -AZAHETEROCICLILAMIDA.
ATE336997T1 (en) FULVIC ACID AND ITS USE IN THE TREATMENT OF VARIOUS MEDICAL CONDITIONS
ES2130152T3 (en) MEDICINES TO TREAT INFLAMMATORY PAIN OR ANALGESIA CONTAINING A NSAID AND RANITIDINE / BISMUTE CITRATE.
SE9701161D0 (en) New use I
IL154210A0 (en) Methods and pharmaceutical compositions for healing wounds
ES2134237T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING URSODESOXICOLICO ACID.
AR010432A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RICHINOLEIC ACID AND ITS USE FOR ANTI-INFLAMMATORY AND ANALGESIC THERAPY
DE60031016D1 (en) Use of antiseptics for the preparation of medicaments for the prophylaxis and treatment of inflammation in the interior of the human body
ECSP034470A (en) 6.ALFA., 9.ALFA-DIFLUOR-17.ALFA.- (2-FURANILCARBOXILO) OXY-11.BETA.-HIDROXI-16.ALFA.-METIL-3-OXO-ANDROST-1,4, -DIENE- 17-S-FLUORMETILE ESTER CARBOTIOTIC ACID AS AN ANTI-INFLAMMATORY AGENT
DK1455849T3 (en) Wound Care device
ES2125356T3 (en) USE OF LEFLUNOMIDE FOR INTERLEUKIN INHIBITION 8.
ES2059204T3 (en) DERIVATIVES OF HYDROXAMIC ACID LIPOXIGENASE INHIBITORS.
HUP0204180A2 (en) External composition and its use for treating of allergic skin diseases
ES2146683T3 (en) USE OF BIPHEMELAN FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HYPERCINETIC DISORDERS.
ES2058378T3 (en) ANTI-INFLAMMATORY AGENT FOR PROSTATIC HYPERTROPHY THERAPY, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOUNDS THAT CONTAIN IT.
ES2062752T3 (en) PREPARED FROM AN OXYPURINOL SALT IN ORAL FORM FOR THE TREATMENT OF HYPERURICEMIA.
AR004353A1 (en) METHOD TO MEDICATE THE INFLAMMATORY CONTROL SYSTEM AND ADVERSE INFLAMMATORY REACTIONS AND TO MANUFACTURE COMPOUNDS FOR THE TREATMENT OF THE LABOR OF ADVERSE INFLAMMATORY REACTIONS.
MX9301108A (en) USE OF AN ANTAGONIST SEROTONIN COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO PROMOTE WOUND HEALING, A COMPOSITION CONTAINING SUCH MEDICINAL PRODUCT, AND A METHOD FOR PREPARING IT.
BR0013552A (en) Topical azathioprine for the treatment of oral autoimmune diseases